This page in English
Laddar profil information

Publikationer

GABA receptor occupancy by subtype selective GABA modulators: PET studies in humans
Jucaite A, Cselényi Z, Lappalainen J, Mccarthy Dj, Lee Cm, Nyberg S, et al
Psychopharmacology 2017;234(4):707-716

A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates
Hjorth S, Karlsson C, Jucaite A, Varnäs K, Wählby Hamrén U, Johnström P, et al
Neuropharmacology 2016;101():519-30

In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects
Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, et al
Brain, behavior, and immunity 2016;54():149-57

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease
Jucaite A, Svenningsson P, Rinne Jo, Cselényi Z, Varnäs K, Johnström P, et al
Brain : a journal of neurology 2015;138(Pt 9):2687-700

A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Jucaite A, Öhd J, Potter As, Jaeger J, Karlsson P, Hannesdottir K, et al
Psychopharmacology 2014;231(6):1251-65

A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers
Varnäs K, Jučaite A, Mccarthy Dj, Stenkrona P, Nord M, Halldin C, et al
Cephalalgia : an international journal of headache 2013;33(10):853-60

AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects
Jucaite A, Takano A, Boström E, Jostell Kg, Stenkrona P, Halldin C, et al
The international journal of neuropsychopharmacology 2013;16(6):1231-9

Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum
De Manzano Ö, Cervenka S, Jucaite A, Hellenäs O, Farde L, Ullén F
NeuroImage 2013;67():1-6

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR
Nyberg S, Jucaite A, Takano A, Kågedal M, Cselényi Z, Halldin C, et al
The international journal of neuropsychopharmacology 2013;16(10):2235-44

Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate
Schou M, Varnäs K, Jucaite A, Gulyás B, Halldin C, Farde L
Nuclear medicine and biology 2013;40(3):410-4

Diurnal Melatonin Patterns in Children: Ready to Apply in Clinical Practice?
Praninskiene R, Dumalakiene I, Kemezys R, Mauricas M, Jucaite A
PEDIATRIC NEUROLOGY 2012;46(2):70-6

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
Jučaite A, Cselényi Z, Arvidsson A, Ahlberg G, Julin P, Varnäs K, et al
EJNMMI research 2012;2():15-

Melatonin secretion in children with epilepsy
Praninskiene R, Dumalakiene I, Kemezys R, Mauricas M, Jucaite A
EPILEPSY & BEHAVIOR 2012;25(3):315-22

Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy
Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, et al
NeuroImage 2012;59(4):3582-93

Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
Nord M, Nyberg S, Brogren J, Jucaite A, Halldin C, Farde L
The international journal of neuropsychopharmacology 2011;14(10):1357-66

Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study
Jucaite A, Forssberg H, Karlsson P, Halldin C, Farde L
Neuroscience 2010;167(1):104-10

Changes in cortical dopamine D1 receptor binding associated with cognitive training
Mcnab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, et al
Science (New York, N.Y.) 2009;323(5915):800-2

Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy
Ciumas C, Wahlin Tb, Jucaite A, Lindstrom P, Halldin C, Savic I
Neurology 2008;71(11):788-94

Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study
Jucaite A, Odano I, Olsson H, Pauli S, Halldin C, Farde L
European journal of nuclear medicine and molecular imaging 2006;33(6):657-68

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L
Biological psychiatry 2005;57(3):229-38

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration
Talvik M, Nordström Al, Larsen Ne, Jucaite A, Cervenka S, Halldin C, et al
Psychopharmacology 2004;175(2):148-53

Deficient coordination of associated postural adjustments during a lifting task in children with neurodevelopmental disorders
Jucaite A, Fernell E, Forssberg H, Hadders-algra M
Developmental medicine and child neurology 2003;45(11):731-42

[Dopaminergic modulation of cerebral activity and cognitive functions]
Jucaite A
Medicina (Kaunas, Lithuania) 2002;38(4):357-62

Shared memory representations for programming of lifting movements and associated whole body postural adjustments in humans
Forssberg H, Jucaite A, Hadders-algra M
Neuroscience letters 1999;273(1):9-12

Investigations of pneumocystosis among humans and rodents in Lithuania
Bajoriniené Dj, Jucaite A
Wiadomosci parazytologiczne 1997;43(1):53-9

Visa alla publikationer